Responses
Oncolytic and local immunotherapy
Original research
Tigilanol tiglate is an oncolytic small molecule that induces immunogenic cell death and enhances the response of both target and non-injected tumors to immune checkpoint blockade
Compose a Response to This Article
Other responses
No responses have been published for this article.
